Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itaru Hashimoto

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
In Vivo (Athens, Greece)|August 31, 2023
Influence of the Oral Health Assessment Tool Score on Survival of Patients With Esophageal CancerHiroshi Tamagawa, Ayako Tamagawa, Toru Aoyama, et al.
In Vivo (Athens, Greece)|February 28, 2024
Albumin-Globulin Ratio Is an Independent Prognostic Factor for Gastric Cancer Patients who Received Curative TreatmentMomoko Fukuda, Toru Aoyama, Itaru Hashimoto, et al.
Anticancer Research|February 2, 2024
CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative TreatmentToru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
Anticancer Research|September 29, 2020
Clinical Significance of Glioma-associated Oncogene 1 Expression in Patients With Locally Advanced Gastric Cancer Administered Adjuvant Chemotherapy With S-1 After Curative SurgeryItaru Hashimoto, Naohide Oue, Yayoi Kimura, et al.
In Vivo (Athens, Greece)|October 31, 2023
The Clinical Impact of the Pretreatment Platelet-to-Lymphocyte Ratio in Gastric Cancer Patients Who Receive Curative TreatmentToru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
Anticancer Research|February 2, 2024
Comparison of Dietary Intake After Gastric Cancer Gastrectomy Between Patients With and Without Postoperative Surgical ComplicationsMie Tanabe, Toru Aoyama, Masato Nakazono, et al.
Anticancer Research|September 3, 2021
Clinical Significance of Chemokine Receptor CXCR4 and CCR7 mRNA Expression in Patients With Colorectal CancerShinsuke Nagasawa, Kazuhito Tsuchida, Manabu Shiozawa, et al.
Anticancer Research|December 30, 2023
Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative TreatmentToru Aoyama, Aya Kato, Itaru Hashimoto, et al.
In Vivo (Athens, Greece)|June 30, 2026
Albumin to Globulin Ratio Is an Independent Prognostic and Predictive Factor for Recurrence of Esophageal Cancer After EsophagectomyMamoru Uchiyama, Toru Aoyama, Yukio Maezawa, et al.
Journal of Cancer Research and Clinical Oncology|November 23, 2019
High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1Yukio Maezawa, Kentaro Sakamaki, Naohide Oue, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
In Vivo (Athens, Greece)|August 31, 2023
Influence of the Oral Health Assessment Tool Score on Survival of Patients With Esophageal CancerHiroshi Tamagawa, Ayako Tamagawa, Toru Aoyama, et al.
In Vivo (Athens, Greece)|February 28, 2024
Albumin-Globulin Ratio Is an Independent Prognostic Factor for Gastric Cancer Patients who Received Curative TreatmentMomoko Fukuda, Toru Aoyama, Itaru Hashimoto, et al.
Anticancer Research|February 2, 2024
CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative TreatmentToru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
Anticancer Research|September 29, 2020
Clinical Significance of Glioma-associated Oncogene 1 Expression in Patients With Locally Advanced Gastric Cancer Administered Adjuvant Chemotherapy With S-1 After Curative SurgeryItaru Hashimoto, Naohide Oue, Yayoi Kimura, et al.
In Vivo (Athens, Greece)|October 31, 2023
The Clinical Impact of the Pretreatment Platelet-to-Lymphocyte Ratio in Gastric Cancer Patients Who Receive Curative TreatmentToru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
Anticancer Research|February 2, 2024
Comparison of Dietary Intake After Gastric Cancer Gastrectomy Between Patients With and Without Postoperative Surgical ComplicationsMie Tanabe, Toru Aoyama, Masato Nakazono, et al.
Anticancer Research|September 3, 2021
Clinical Significance of Chemokine Receptor CXCR4 and CCR7 mRNA Expression in Patients With Colorectal CancerShinsuke Nagasawa, Kazuhito Tsuchida, Manabu Shiozawa, et al.
Anticancer Research|December 30, 2023
Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative TreatmentToru Aoyama, Aya Kato, Itaru Hashimoto, et al.
In Vivo (Athens, Greece)|June 30, 2026
Albumin to Globulin Ratio Is an Independent Prognostic and Predictive Factor for Recurrence of Esophageal Cancer After EsophagectomyMamoru Uchiyama, Toru Aoyama, Yukio Maezawa, et al.
Journal of Cancer Research and Clinical Oncology|November 23, 2019
High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1Yukio Maezawa, Kentaro Sakamaki, Naohide Oue, et al.
Pageof 13